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Summary
Acute pulmonary embolism (PE) often decreases pulmonary diffusing capacity for
carbon monoxide (DL,CO), but data on the mechanisms involved are inconsistent.
We wanted to investigate whether reduction in diffusing capacity of alveolo-
capillary membrane (DM) and pulmonary capillary blood volume (Vc) is associated
with the extent of PE or the presence and severity of right ventricular dysfunction
(RVD) induced by PE and how the possible changes are corrected after 7-month
follow-up. Forty-seven patients with acute non-massive PE in spiral computed
tomography (CT) were included. The extent of PE was assessed by scoring mass of
embolism. DL,CO, Vc, DM and alveolar volume (VA) were measured by using a
single breath method with carbon monoxide and oxygen both at the acute phase and
7 months later. RVD was evaluated with transthoracic echocardiography and
electrocardiogram. Fifteen healthy subjects were included as controls. DL,CO, DL,
CO⁄VA, DM, vital capacity (VC) and VA were signiﬁcantly lower in the patients with
acute PE than in healthy controls (P<0Æ001). DM⁄Vc relation was signiﬁcantly lower
in patients with RVD than in healthy controls (P =0 Æ004). DM correlated inversely
with central mass of embolism (r = )0Æ312; P =0 Æ047) whereas Vc did not. DM,
DL,CO, VC and VA improved signiﬁcantly within 7 months. In all patients
(P =0 Æ001, P =0 Æ001) and persistent RVD (P =0 Æ020, P =0 Æ012), DM and DL,CO
remained signiﬁcantly lower than in healthy controls in the follow-up. DM was
inversely related to central mass of embolism. Reduction in DM mainly explains the
sustained decrease in DL,CO in PE after 7 months despite modern treatment of PE.
Introduction
Acute pulmonary embolism (PE) is known to be associated with
decreased pulmonary diffusing capacity for carbon monoxide
(DL,CO) (Sharma et al., 1980) reﬂecting deterioration of gas
exchange capacity of the lungs. However, the mechanisms
behind decreased DL,CO in PE are still in many ways obscure.
The transfer of carbon monoxide (CO) through the alveolo-
capillary membrane depends on the diffusing capacity of the
membrane itself (DM), the pulmonary capillary blood volume
(Vc) and haemoglobin concentration of blood. Some earlier
studies have suggested that the reduction in DL,CO in PE would
be owing to loss of alveolar volume (VA) (Pande et al., 1975;
Fennerty et al., 1988; Wimalaratna et al., 1989) rather than
owing to decrease in Vc (Sharma et al., 1980). Other authors
have proposed that reduction in DM related to Vc in chronic
thromboembolic pulmonary hypertension (Bernstein et al.,
1996) or in chronic thromboembolic disease (Oppenheimer
et al., 2006) would cause the reduced DL,CO. Some have found
in chronic thromboembolic hypertension both Vc and DM to be
reduced (Steenhuis et al., 2000). Thus, the previous studies have
resulted in conﬂicting results.
PE displays a wide spectrum of clinical severity, depending on
the size and distribution of the embolic mass. In high-risk and
intermediate-risk cases of PE (massive and submassive PE), right
ventricular dysfunction (RVD) is observed.
The aim of the study was to analyse changes in the
components of diffusing capacity in acute PE. We measured
DL,CO, DM, Vc and lung volume and correlated them with the
indices of the extent of PE. The measurements were repeated
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diffusing capacity and its components were associated with the
extent of PE (measured as either total, central or peripheral mass
of embolism), or with PE-induced RVD. For comparison,
healthy control subjects were also studied. In addition, the
patients were re-evaluated after 7 months to see how the
possible changes would be corrected after evidence-based
therapy.
Methods and materials
Patients and study design
We studied 47 consecutive patients (24 women, 23 men) with
acute non-massive, non-high-risk PE conﬁrmed by computer-
ized tomography (CT) at the Emergency Department of Helsinki
University Central Hospital. Patients were recruited between
January 2003 and August 2004. Exclusion criteria comprised
clinically massive PE (haemodynamically unstable patients),
chronic pulmonary disease requiring regular medication,
previous PE, non-stable angina pectoris, patients on anticoag-
ulation therapy and terminal cancer (with estimated life
expectancy of less than 7 months). In addition, patients arriving
at the hospital between Friday 18:00 and Sunday 12:00 were
excluded because the services of the laboratory of clinical
physiology were unavailable at that time. For those included in
the study, echocardiography (ECHO) and lung function studies
were performed.
Patients were given antithrombotic treatment according
to current guidelines at the time of the study (Torbicki et al.,
2000). Most of the patients were treated initially with low
molecular weight heparin, followed by warfarin for ‡6 months.
Seven months later, diffusing capacity measurements were
repeated and ﬂow-volume spirometry was performed. ECHO
was also repeated to identify patients with RVD.
Fifteen healthy, age-matched controls (nine women, six men)
were also studied – in 12 of them (three of the controls did not
cooperate to come to the second measurement), the measure-
ments were repeated later, correspondingly to the patients. The
anthropometric data and smoking history of the patients and
healthy controls are presented in Table 1.
The study protocol was approved by the ethics committee of
Helsinki University Hospital, and informed consent was signed
by all participants.
Lung function methods
Measurements of DL,CO with DM and Vc determinations were
performed within 24 h from PE diagnosis. For measurement of
DL,CO, single breath method according to Viljanen (1982) was
used applying the European Respiratory Society recommenda-
tions (McIntyre et al., 2005). Slow vital capacity (VC) was
measured ﬁrst, and the inspiratory volume for 10-s breath
holding was standardized to 90% of measured VC. At least two
successive determinations were performed, and the mean value
was recorded for analysis. In addition, VC, VA and speciﬁc
diffusing capacity (DL,CO⁄VA) were determined (McIntyre
et al., 2005). DM, Vc and rate of uptake of CO by red cells per
mmHg of CO tension (h) were determined according to
Roughton and Forster (1957; Roughton et al., 1957). Two
different gas mixtures were used (i) oxygen 21%, helium 7%,
CO 0Æ25% and nitrogen the rest and (ii) oxygen 93%, helium
about 7% and CO 0Æ25%. The measurements were accomplished
with a Jaeger MasterScreen PFT equipment (Wu ¨rzburg,
Germany). Diffusing capacity values were corrected according
to actual haemoglobin concentration in blood (McIntyre et al.,
2005). Reference values of Viljanen (1982) for Finnish
population were used for DL,CO and DL,CO⁄VA values and
those of Zanen et al. (2001) for DM and Vc values.
To exclude patients with pulmonary obstruction, ﬂow-
volume spirometry was performed on PE patients 7 months
after the acute phase in the patients and at the ﬁrst visit from the
control subjects with a pneumotachograph connected with a
microcomputer (Medikro MR-3; Medikro, Kuopio, Finland)
(Table 2). For safety reasons, forced spirometry was not
performed at the acute phase. Reference values of Viljanen
(1982) were used. The ﬂow-volume curve for analysis was
compiled from at least three successive forced expiratory curves
Table 1 The gender and anthropometric data of the patients with
pulmonary embolism (PE) and the healthy control subjects.
Patients
with PE
Healthy
controls
Signiﬁcance
in t-test
Gender, male⁄
female (number)
23⁄24 6⁄9
Weight (kg) 88Æ9 (18Æ1) 73Æ0 (11Æ2) 0Æ002
Height (cm) 172Æ0 (10Æ4) 173Æ0 (11Æ1) 0Æ730
Age (year) 56Æ1 (16Æ3) 55Æ0 (16Æ5) 0Æ881
Smoking (pack-years) 3Æ92 (7Æ6) 2Æ67 (6Æ0) 0Æ469
Number (percent) of
non-smokers 30 (63Æ8) 11 (73Æ3) 0Æ761*
smokers 7 (14Æ9) 2 (13Æ3)
exsmokers 10 (21Æ3) 2 (13Æ3)
*Chi-square test.
Table 2 Spirometric data of patients and healthy controls. ANCOVA,
used adjustment thoroughly in the methods chapter.
Variable
Patients
(N = 47)
Controls
(N = 15)
Signiﬁcance of
the difference Mean (SD) Mean (SD)
FVC (l) 3Æ6( 1 Æ2) 4Æ1( 1 Æ1) 0Æ167
FVC (%) 88Æ3 (14Æ4) 101Æ2 (17Æ1) 0Æ039
FEV1 (l) 2Æ9( 0 Æ93) 3Æ4( 0 Æ88) 0Æ051
FEV1 (%) 88Æ0 (15Æ0) 97Æ9 (28Æ3) 0Æ098
FEV1⁄FVC (%) 80Æ8( 5 Æ3) 83Æ1( 6 Æ3) 0Æ180
MEF 50 (l s
)1)3 Æ2( 1 Æ4) 4Æ2( 1 Æ3) 0Æ050
MEF50 (%) 74Æ8 (26Æ7) 95Æ7 (27Æ9) 0Æ014
FVC, forced vital capacity; VC, vital capacity.
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197using the envelope method according to the European Respi-
ratory Society (Quanjer Ph et al., 1993) guidelines. The
following variables were measured: forced vital capacity
(FVC), forced expiratory volume in one second (FEV1) and
forced expiratory ﬂow at a level where 50% of FVC remains to
be exhaled (MEF50).
Quantifying the extent of pulmonary embolism and right
ventricular dysfunction
Spiral computerized tomography (CT) angiographic studies of
pulmonary arteries were performed with an 8-slice, 4-slice or
single-slice scanner in 27, 18 and 2 patients, respectively. The
volume of contrast material varied between 90 and 120 ml
and was injected with a power injector using bolus tracking.
Slice thickness was 1 or 1Æ25 mm in the multi-slice scanners
and 3 mm in the single-slice scanner. Studies were analysed on
a CT workstation by two experienced radiologists, using
different window settings and 2D reformations when needed.
Mass of embolism was scored using the method of Mastora
et al. (2003), in which the percentage of obstructed surface of
each artery is evaluated using a 5-point scale. The score for
mass of embolism is 0–55 for central emboli (thrombus in
mediastinal or lobar arteries) and 0–100 for peripheral
(segmental) arteries. The total score for mass of embolism is
thus 0–155. If the embolism was only in subsegmental
arteries, the count was 0.
Transthoracic ECHO was performed within 24 h of PE
diagnosis. The presence of RVD was assessed using established
echocardiographic criteria: (i) increased right ventricular to left
ventricular (RV⁄LV) ratio of end-diastolic diameter (>0Æ9) at
the left parasternal long axis, (ii) wall-motion abnormality of
the interventricular septum and (iii) peak velocity of tricuspid
regurgitation >2Æ8m⁄s (Ribeiro et al., 1997; Torbicki et al.,
2000; Goldhaber, 2002). At least one of these three criteria
had to be positive. ECHO was performed by one of three
experienced cardiologists blinded to the results of biochemical
assays. A 12-lead ECG at rest was also recorded. Criteria for signs
of right ventricular overload in ECG were T-wave inversion in
leads V1-V3, incomplete or complete right bundle branch block,
S1Q3T3 or signs of right atrial enlargement (Geibel et al., 2005,
Punukollu et al., 2005).
Statistical methods
The lung function variables were compared between patients
and controls with independent samples t-test. Correlation
methods were used to determine the covariants, and the results
were adjusted for them by using general linear model procedure
analysis of covariance (ANCOVA). For the variables used as per
cent of predicted values, the results were adjusted to pack years
and also to weight if weight was not calculated in the reference
value; for the variables used as absolute values, the results were
adjusted height, weight, age and smoking. In multiple com-
parisons, Bonferroni correction was used. In text, the results are
reported as absolute values, because for all variables, reference
values were not available. In addition, results are reported as per
cent of reference values in the tables.
Partial correlation was used to adjust the lung function
variables for age, height, weight and smoking. If the variables
were dealt with as per cent of reference values, they were
adjusted for smoking. Also weight and height were adjusted for
if they were not included in the reference values.
The change in the studied variables during follow-up was
analysed with paired t-test or with Wilcoxon s pairwise test
when the variable was not normally distributed. To evaluate the
inﬂuence of lung volume on the observed changes, the
difference in VA between the acute and recovery phases of PE
was compared in regression analysis with the corresponding
difference in DL,CO, DL,CO⁄VA, DM or Vc between the
examination phases. SPSS Windows version 15.0 (IBM Corpora-
tion, Somers, NY, USA) was used in all calculations.
Results
Acute phase
The total score for mass of embolism varied between 0 and 110
(mean, SD; 54Æ1, 32Æ4), corresponding 0–71% obstruction of
the total pulmonary artery bed. Forty patients had both central
and peripheral emboli. Seven patients had peripheral emboli
only and one of them subsegmental emboli only, resulting in
score 0 in that case. The score for central mass of embolism
varied 0–34 (mean, SD; 17Æ5, 1Æ8), corresponding 0–62%
obstruction of central pulmonary artery bed. The scores for
peripheral mass of embolism ranged from 0 to 82 (37Æ0, 22Æ5),
meaning 0–82% obstruction of peripheral pulmonary artery
bed. Signs of RVD in ECHO were present in 24 patients (51%),
in CT 29 (63%) or in ECG 23 (42Æ6%). The comparisons
between patients with and without RVD are given based on
ECHO examination, because ECHO examination was available
also at the control phase. Associated with PE, two patients
(3Æ7%) had ﬁndings of pulmonary infarction, four patients
(7Æ4%) atelectasis and four patients (7Æ4%) pleural ﬂuid; all
these ﬁndings were slight.
VC, VA, DL,CO, DL,CO⁄VA and DM were signiﬁcantly lower
in patients with acute PE than in the healthy controls (Table 3).
In patients, DL,CO (r =0 Æ708; P<0Æ001), DM (0Æ447,
P =0 Æ003) and Vc (r =0 Æ502, P =0 Æ001) correlated signiﬁ-
cantly with VA.
DM did not correlate signiﬁcantly with total or peripheral
mass of embolism, but scores for central mass of embolism
showed a signiﬁcant negative correlation with DM (Fig. 1). Vc
did not correlate signiﬁcantly with scores for mass of embolism.
DL,CO⁄VA was suggestively lower in those with RVD than in
those without RVD. VC, VA, DL,CO, DL,CO⁄VA, DM and
DM⁄Vc relations were signiﬁcantly lower in patients with RVD
compared with healthy controls. VC, VA, DL,CO and DM were
signiﬁcantly lower in patients without RVD compared with
healthy controls (Table 4).
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198Recovery phase (7 months)
In patients, most lung function variables improved during
7-month follow-up (Table 3), the increase in DM was in mean
14Æ3% (SD 28%), P<0Æ001, and in Vc 9Æ96% (SD 35%)
P =0 Æ159 (Table 3). The increase in VA explained the
improvement in DL,CO (P =0 Æ008) and DM (P =0 Æ029).
DL,CO, DL,CO⁄VA, DM and Vc remained signiﬁcantly lower
in the patients when compared to the controls (Table 3). In all
patients, DL,CO (r =0 Æ782, P<0Æ001), DM (r =0 Æ642;
P <0 Æ001) and Vc (r =0 Æ467; P =0 Æ002) correlated signiﬁ-
cantly with VA.
At 7 months, the size and function of the right ventricle had
normalized in most patients with RVD at the baseline (24⁄47,
51%), but still 5⁄47 patients (10Æ6%) had RVD in ECHO. In
patients with persistent RVD at 7 months, DM was suggestively
lower than in those without RVD or signiﬁcantly lower than in
healthy controls (Fig. 2). Also DL,CO remained signiﬁcantly
lower in those with RVD than in healthy controls (Fig. 3). In
patients with permanent RVD, the correlations between VA and
DL,CO, DL,CO⁄VA, DM or Vc were not signiﬁcant.
Discussion
This study shows that diffusing capacity (DL,CO) and especially
its alveolo-capillary membrane component (DM) are decreased
in acute PE. The extent of PE and the severity of RVD were
inversely associated with DL,CO and DM; the larger the PE, the
lower the DL,CO or DM, ﬁndings not reported previously.
Although DL,CO and DM increased during the 7-month
recovery phase, they still remained lower than in healthy
control subjects, especially in patients with persistent RVD. In
persistent RVD, the reduction in DM seemed to be independent
of lung volume.
As far as we know, the present study is the largest follow-up
study in PE in which the components of diffusing capacity have
been evaluated. Earlier, Fennerty et al.(1988) conducted a
smaller study including 14 patients with PE with a 3-month
follow-up and found DL,CO to be the best in differentiating
between patients and controls, and DM to be lower in patients
than in controls, but the difference in the latter – in contrary to
Table 3 Lung function data of patients and the healthy controls during the acute phase and at the recovery phase (7-month later). Mean and standard
deviations are presented for all variables.
Variable
Patients,
acute
Phase
N =4 7
Controls,
acute
phase,
N =1 5
Statistical
signiﬁcance of
comparison
between patients
and controls,
acute phase
(P-value)
a,b
Patients,
recovery
phase
N =4 7
Statistical
signiﬁcance of
comparison
of patients between
acute and
recovery phases
(P-value)
a,c
Controls,
recovery
phase
N =1 2
Statistical
signiﬁcance of
comparison
between patients
and controls,
recovery phase
(P-value)
a,b
VC (l) 3Æ5( 1 Æ1) 4Æ4( 1 Æ1) 0Æ022 3Æ80 (1Æ19) <0Æ001 4Æ25 (1Æ17) 0Æ514
VC (%) 83Æ3 (15Æ5) 103Æ9 (14) <0Æ001 90Æ3 (16Æ4) <0Æ001 104Æ1 (15Æ2) 0Æ478
VA (l) 4Æ3( 1 Æ1) 5Æ5( 1 Æ3) 0Æ002 4Æ7( 1 Æ2) <0Æ001 5Æ1( 1 Æ15) 0Æ432
DL,CO (mmol min
)1kPa
)1)5 Æ9( 1 Æ8) 8Æ3( 2 Æ5) <0Æ001 6Æ6( 2 Æ1) <0Æ001 8Æ2( 2 Æ5) 0Æ001
DL,CO (%) 73Æ7 (13Æ6) 103Æ7 (15Æ2) <0Æ001 81Æ3 (14Æ4) <0Æ001 101Æ1 (15Æ59) 0Æ003
DL,CO⁄VA
(mmol min
)1kPa
)1 l
)1)
1Æ39 (0Æ2) 1Æ48 (0Æ2) 0Æ008 1Æ30 (0Æ24) 0Æ568 1Æ47 (0Æ27) 0Æ012
DL,CO⁄VA (%) 94Æ6 (14Æ5) 104Æ4 (13Æ7) 0Æ032 96Æ3 (14Æ4) 0Æ278 104Æ8 (17Æ2) 0Æ025
DM (mmol min
)1 kPa
)1)9 Æ1( 3 Æ0) 13Æ9( 4 Æ7) <0Æ001 10Æ3( 3 Æ8) 0Æ001 13Æ6( 4 Æ9) 0Æ001
DM (%) 49Æ3 (15Æ6) 72Æ3 (22Æ8) <0Æ001 55Æ0 (19Æ3) 0Æ003 71Æ7 (28Æ7) 0Æ008
Vc (ml) 53Æ6 (16Æ1) 63Æ9 (22Æ6) 0Æ157 56Æ6 (16Æ5) 0Æ159 69Æ3 (19Æ5) 0Æ040
Vc (%) 68Æ7 (17Æ2) 79Æ3 (19Æ4) 0Æ062 72Æ0 (16Æ5) 0Æ173 85Æ8 (18Æ1) 0Æ049
DM⁄Vc relation 0Æ18 (0Æ09) 0Æ22 (0Æ06) 0Æ131 0Æ19 (0Æ09) 0Æ770 0Æ21 (0Æ11) 0Æ344
VA, alveolar volume; VC, vital capacity; DM, diffusing capacity of alveolo-capillary membrane; Vc, pulmonary capillary blood volume.
aLevel of signiﬁcance according to Bonferroni correction is 0Æ004.
bnon-paired ANCOVA, adjustments are thoroughly given in the methods chapter.
cpaired t-test.
Figure 1 Association of the diffusing capacity of the alveolo-capillary
membrane with central embolism mass. The calculation was made with
partial correlation with adjustment with age, smoking at pack years,
height and weight.
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199the present results – did not reach statistical signiﬁcance. In the
present study, more exact characterization of the embolism mass
could be obtained than in the previous study (Fennerty
et al.,1988), which used a ventilation-perfusion isotope scan
with only a crude estimation of the size of PE. However, also
with CT methods, high correlations were not found, which may
depend on the heterogeneity of the embolism mass. As far as we
know, the present paper is the ﬁrst study to use the CT-based
scoring of mass of embolism in relation to the components of
diffusing capacity.
The results indicate that also the area of the alveolo-capillary
membrane affected by thrombus, i.e. the extent of PE, is
responsible for reduction in DL,CO at the acute phase of PE, in
addition to the effect of reduction in lung volume. Loss of lung
volume is important in the mechanism of decreased DL,CO
explained by bronchoconstriction in terminal respiratory units
corresponding to the site of PE (Nadel et al., 1964).
VC and VA improved signiﬁcantly 7 months after the acute
PE. In the recovery phase, the correlation between DM and VA
remained signiﬁcant in all patients, but in patients with
sustained RVD, VA seems to be a less important cause of
reduction in DM and DL,CO. In patients with RVD, eventually a
Figure 2 Diffusing capacity of membrane in the recovery phase. A
suggestive difference existed between patients with and without right
ventricular dysfunction (RVD), a signiﬁcant difference between patients
without RVD and healthy controls, as well as between patients with RVD
and healthy controls (ANCOVA, adjustment according to age, height,
weight and smoking). The level of signiﬁcance after Bonferroni
correction is 0Æ02.
Figure 3 Diffusing capacity (DL,CO) in the recovery phase. A
signiﬁcant difference existed between patients without right
ventricular dysfunction (RVD) and healthy controls and between
patients with RVD and healthy controls (ANCOVA, adjustment
according to smoking). The level of signiﬁcance after Bonferroni
correction is 0Æ02.
Table 4 The results of patients with and without right ventricular dysfunction (RVD) in echocardiography in the acute phase of pulmonary
embolism. Also the comparisons of them with healthy controls are presented (non-paired ANCOVA).
Variable
Patients
without
RVD
(N = 23)
Patients
with
RVD
(N = 24)
Healthy
controls
(N = 15)
Statistical
signiﬁcance of
comparison
between
patients with
and without
RVD (P-value)
a,b
Statistical
signiﬁcance
of comparison
between
patients
with RVD
and controls
(P-value)
a,b
Statistical
signiﬁcance
of comparison
between
patients
without RVD
and controls
(P-value)
a,b
VC (l) 3Æ5( 1 Æ2) 3Æ4( 1 Æ0) 4Æ4( 1 Æ1) 0Æ618 0Æ013 0Æ064
VC (%) 83Æ3 (18Æ4) 83Æ2 (13Æ5) 103Æ9 (14) 0Æ988 <0Æ001 0Æ001
VA (l) 4Æ37(1Æ17) 4Æ27 (0Æ98) 5Æ5( 1 Æ3) 0Æ596 0Æ006 0Æ012
DL,CO (mmol min
)1 kPa
)1)6 Æ3( 1 Æ9) 5Æ67 (1Æ7) 8Æ3( 2 Æ5) 0Æ218 <0Æ001 0Æ002
DL,CO (%) 76Æ8 (14Æ2) 71Æ0 (13Æ3) 103Æ7 (15Æ2) 0Æ139 <0Æ001 <0Æ001
DL,CO⁄VA (mmol min
)1kPa
)1 l
)1)1 Æ46 (0Æ25) 1Æ32 (0Æ23) 1Æ48 (0Æ2) 0Æ015 0Æ009 0Æ062
DL,CO⁄VA (%) 94Æ6 (14Æ5) 104Æ4 (13Æ7) 104Æ4 (13Æ7) 0Æ025 0Æ007 0Æ293
DM (mmol min
)1 kPa
)1)9 Æ7( 3 Æ0) 8Æ5( 3 Æ0) 13Æ9( 4 Æ7) 0Æ185 <0Æ001 0Æ001
DM (%) 51Æ7 (16Æ4) 46Æ4 (14Æ5) 72Æ3 (22Æ8) 0Æ383 <0Æ001 0Æ003
Vc (ml) 55Æ8 (17Æ6) 51Æ4 (14Æ6) 63Æ9 (22Æ6) 0Æ446 0Æ333 0Æ211
Vc (%) 70Æ6 (18Æ9) 66Æ0 (15Æ9) 79Æ3 (19Æ4) 0Æ441 0Æ043 0Æ195
DM⁄Vc relation 0Æ19 (0Æ12) 0Æ17 (0Æ06) 0Æ22 (0Æ06) 0Æ484 0Æ004 0Æ674
VA, alveolar volume; VC, vital capacity; DM, diffusing capacity of alveolo-capillary membrane; Vc, pulmonary capillary blood volume.
aLevel of signiﬁcance according to Bonferroni correction is 0Æ004.
bnon-paired ANCOVA, adjustments are thoroughly explained in the methods chapter.
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200decrease in the area of functional alveolar membrane occurs,
because of organized thrombus, medial hypertrophy or intimal
ﬁbrosis, as described earlier in chronic thromboembolic
pulmonary hypertension, a disease more advanced than the
disease of the present patients with RVD (Moser & Bloor, 1993).
At 7 months, DM probably reﬂects more the properties of
alveolo-capillary membrane whereas in the acute phase, DM
reduction might reﬂect more the mass of embolism. However,
the method used in the present study cannot differentiate
between the causes of DM reduction. In addition, the small
number of those with persistent RVD reduces the power of these
ﬁndings in the recovery phase.
As a rule, PE causes RVD when at least 25% (Goldhaber,
1998) of the pulmonary arterial bed is occluded by a thrombus.
Increase in pulmonary arterial pressure in PE increases right
ventricular afterload and consequently leads to dilatation and
failure of the right ventricle. The larger the mass of embolism,
the more common and severe the RVD. In general, approxi-
mately half of the patients with acute PE have RVD (Goldhaber,
1998; Miller et al.,1998, Lankeit & Konstantinides, 2010). The
prevalence of RVD of 51% in the acute phase of the present
study is in line with that.
As it concerns Vc, we did not ﬁnd a signiﬁcant difference in its
values between healthy controls and patients at the acute phase,
whichisinconcordancetooneolderstudy(Fennertyet al.,1988).
Either did Vc not improve during the follow-up. There are also
earlier studies on PE (Fennerty et al., 1988) and chronic throm-
boembolicdisease(Bernsteinet al.,1996)whichreportthatVcdid
not recover after therapeutic procedures, although there are also
suggestionsontheroleofVcinthereductioninDL,COinchronic
thromboembolic disease (Steenhuis et al., 2000).
In the present study, DM⁄Vc was signiﬁcantly lower in
patients with RVD compared with those without RVD, suggest-
ing a role of DM⁄Vc relation in the pathophysiology of RVD.
Reduction in the effective capillary volume in PE has been
suggested to cause vascular dilatation, leading to reduction in
the DM⁄Vc ratio (Pande et al., 1975; Oppenheimer et al., 2006).
In the present study, there was improvement in both the values
of DM and Vc why their relation possibly did not signiﬁcantly
change during the follow-up.
The method used to measure the components of diffusing
capacity is a well-established one (Roughton & Forster, 1957),
although it has less commonly been utilized in recent years. The
reference values of Zanen et al. (2001) were chosen because they
are the most recent ones.
The levels of Vc and DM in the present study were similar to
those in an earlier paper (Fennerty et al., 1988) after the relevant
units had been converted. However, the present study gives new
information on the mechanism and outcome of PE.
In our hospital, PE is routinely diagnosed by CT, as
recommended by international guidelines (Torbicki et al.,
2008). Thus, we wanted to study PE according to modern
praxis. It would be ideal to study both CT and perfusion
scintigraphy. However, this was not possible to arrange and
would have been a heavy protocol with a high radiation dose for
the patients. In addition, the patients arrived acutely at the
hospital, why it was not possible to arrange examination time
for both CT and scintigraphy. CT is not as good as scintigraphy
on discriminating embolism in small arteries or to analyse
peripheral distribution of pulmonary ﬂow. However, in
analysing the extent of central, segmental and larger subseg-
mental emboli, CT is superior to scintigraphy (Remy-Jardin
et al., 1996; Mayo et al., 1997).
In our study population, patients with obstructive pulmonary
disease were excluded based on spirometry. The FEV1⁄FVC ratio
was normal in both patients and controls, indicating that
patients did not have obstruction in medium-sized or large
bronchi. Smoking likely had not induced any signiﬁcant
impairment during the 7-month follow-up. In addition,
statistical calculations were adjusted for smoking. Some smokers
were also present among control subjects. Because there was a
signiﬁcant difference in weight between patients and control
subjects, the statistical calculations were adjusted for weight.
In conclusion, a decrease in diffusing properties of the
alveolo-capillary membrane for carbon monoxide is associated
with the extent of central PE and explains the found sustained
reduction in DL,CO in PE. Vc may also be involved in the
sustained reduction in DL,CO in PE. The diffusing capacity
recovered during the 7-month follow-up but did not reach the
level of healthy controls nor the normal reference range. Our
data provide new knowledge of consequences of PE on lung
function and indicate that sustained reduction in diffusing
capacity may still remain despite the treatment of PE according
to current guidelines.
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